The CANVAS Monkeypox Vaccine Safety Study
The Canadian National Vaccine Safety (CANVAS) Network is a national research platform that monitors vaccine safety after vaccines are approved for use. We are monitoring the safety of the Imvamune (Monkeypox) vaccine in Canada.
Who can participate?
People in British Columbia, Quebec and Ontario who have received a dose of monkeypox vaccine in the last 7 days will be invited to participate in the study.
What does the study involve?
Using web-based surveys, we will collect information about whether or not there have been any changes to your health after receiving the monkeypox vaccine. We will also collect information on change to your health from people who have not received a monkeypox vaccine.
If you have any questions, please email email@example.com to learn more.
If you are interested in joining one of our studies or
would like to be added to our contact list, click below.